Kathleen Mazor to Pandemics
This is a "connection" page, showing publications Kathleen Mazor has written about Pandemics.
Connection Strength
0.874
-
Delude C, Abi-Elias IH, Quinn CC, Adams AS, Magaziner JS, Ito K, Jain P, Gurwitz JH, Mazor KM. Stakeholders' views on priorities essential for establishing a supportive environment for clinical trials in nursing homes. J Am Geriatr Soc. 2022 04; 70(4):950-959.
Score: 0.547
-
Fisher KA, Goldthwait L, Desrochers O, Zemel M, Saphirak C, Malin J, Stone RT, Singh S, Crawford S, Mazor KM. Reasons for COVID-19 vaccination late in the pandemic: A qualitative study. Vaccine. 2025 Apr 19; 53:127084.
Score: 0.170
-
Fisher KA, Bloomstone SJ, Walder J, Crawford S, Fouayzi H, Mazor KM. Attitudes Toward a Potential SARS-CoV-2 Vaccine : A Survey of U.S. Adults. Ann Intern Med. 2020 12 15; 173(12):964-973.
Score: 0.123
-
Gurwitz JH, Quinn CC, Abi-Elias IH, Adams AS, Bartel R, Bonner A, Boxer R, Delude C, Gifford D, Hanson B, Ito K, Jain P, Magaziner JS, Mazor KM, Mitchell SL, Mody L, Nace D, Ouslander J, Reifsnyder JA, Resnick B, Zimmerman S. Advancing Clinical Trials in Nursing Homes: A Proposed Roadmap to Success. J Am Geriatr Soc. 2022 03; 70(3):701-708.
Score: 0.034